Morepen Laboratories Ltd Annually Results

Gross Sales

1,690.43

1,417.53

1,546.83

1,188.06

853.07

Excise Duty

0

0

0

0

0

Net Sales

1,690.43

1,417.53

1,546.83

1,188.06

853.07

Other Operating Income

0

0

0

0

0

Other Income

13.97

6.13

10.31

12.07

9.48

Total Income

1,704.4

1,423.66

1,557.13

1,200.13

862.55

Total Expenditure

1,531.81

1,338

1,410.15

1,069.54

784.55

PBIDT

172.6

85.67

146.98

130.58

78

Interest

3.71

1.98

-7.37

1.79

1.98

PBDT

168.89

83.69

154.35

128.79

76.01

Depreciation

33.47

27.93

27.64

30.28

36.91

Minority Interest Before NP

0

0

0

0

0

Tax

39.23

16.88

22.54

1.42

5.53

Deferred Tax

-0.44

0.2

2.48

0

0

Reported Profit After Tax

96.62

38.68

101.68

97.09

33.58

Minority Interest After NP

0.46

0

0

0

0

Net Profit after Minority Interest

96.16

38.68

101.68

97.09

33.58

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

96.16

38.68

101.68

97.09

33.58

EPS (Unit Curr.)

1.88

0.77

2.26

2.16

0.75

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

102.23

102.23

95.56

89.96

89.96

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.21

6.04

9.5

10.99

9.14

PBDTM(%)

9.99

5.9

9.97

10.84

8.91

PATM(%)

5.71

2.72

6.57

8.17

3.93